Adamas to Present at Upcoming September Investor Conferences
30 Agosto 2021 - 3:11PM
Business Wire
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated
to developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that management will present at the following virtual
investor conferences during the month of September 2021:
- H.C. Wainwright 23rd Annual Global Investment Conference, a
pre-recorded presentation will be available beginning on Monday,
September 13 at 7:00 am ET (4:00 am PT)
- Cantor Fitzgerald Global Healthcare Conference, on Wednesday,
September 29 at 4:40 pm ET (1:40 pm PT)
Replays of both events will be available on the investor
relations section of the Adamas website at
http://ir.adamaspharma.com/events-presentations. The replays will
remain available for approximately 30 days from their original
posting.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines
that reduce the burden of neurological diseases on patients,
caregivers and, society. We are a fully-integrated company focused
on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210830005541/en/
Media: Sarah Mathieson Vice President, Corporate
Communications 510-450-3528 smathieson@adamaspharma.com
Investors: Peter Vozzo Managing Director Westwicke/ICR
443-213-0505 peter.vozzo@westwicke.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Adamas Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Adamas Pharmaceuticals, Inc. Artículos de Noticias